Skip to main content Skip to search Skip to main navigation
Patented technology

Why PMA-Zeolite?

PANACEO’s patented micro-activation makes the difference: maximum binding of harmful substances, clinically proven, CE-certified — Made in Austria.

Discover PMA-Zeolite products
PMA-Zeolite with patented micro-activation for maximum binding of harmful substances in the gut
PMA
Patented micro-activation
CE IIb
Medical device class IIb
6 Mio.+
Products sold
20+
Years of market experience
Definition

What is PMA-Zeolite?

PMA-Zeolite is a patented medical device by PANACEO based on clinoptilolite zeolite of volcanic origin. Through the company’s proprietary PMA activation process (Patented Micro Activation), the crystal structure of the mineral is optimized and its natural adsorption power for harmful substances is enhanced many times over.

Not all zeolite is the same. Quality, purity, and effectiveness can vary considerably depending on origin, processing, and particle size. With PMA technology, PANACEO has developed a process that specifically enhances the natural properties of clinoptilolite zeolite.

The result: PMA-Zeolite has an increased inner surface area, an optimized crystal structure, and a uniform particle size of 1–10 micrometers — the optimal range for maximum binding of harmful substances without nanoparticles.

All PANACEO medical devices are based on this PMA-activated zeolite.

PMA activation increases the inner surface area of the zeolite crystal
PMA activation increases the inner surface area of the zeolite crystal.
The technology

PMA — Patented Micro Activation

A three-stage patented process that transforms zeolite from a raw mineral into a high-performance medical device.

01

Raw material selection

Only the purest clinoptilolite of volcanic origin is selected. Strict incoming inspections verify purity, clinoptilolite content, and freedom from harmful substances.

02

Mechanical activation

The patented PMA process mechanically optimizes the crystal structure — without chemicals, without heat. The inner surface area is increased and the pores are opened.

03

Quality control

Each batch is tested for particle size (1–10 µm), adsorption capacity, and purity. Only after passing inspection is it approved for products.

Comparison

PMA-Zeolite vs. regular zeolite

What happens when zeolite is not activated? The differences are clinically measurable.

Recommended

PMA-Zeolite (PANACEO)

  • Patented micro-activation
  • Optimized crystal structure
  • Increased inner surface area
  • Particle size 1–10 µm (no nano)
  • CE-certified Class IIb
  • Clinically tested effectiveness
  • ISO 13485 quality standard
  • Made in Austria
vs.

Unactivated zeolite

  • No activation
  • Natural, irregular structure
  • Smaller surface area
  • Uneven particle size
  • Often without CE certification
  • Rarely clinically tested
  • Different quality standards
  • Different countries of origin
Quality & safety

Why you should pay attention to certification

PMA-Zeolite is certified as a IIb medical device. This means: strict testing, proven effectiveness, documented safety.

Icon for CE certification Class IIb

CE certification Class IIb

CE class IIb for ingestible medical devices and suitable for long-term use. Stricter requirements than for dietary supplements — comparable to pharmaceutical standards.

Icon for ISO 13485 quality management

ISO 13485 quality management

International standard for the manufacturing of medical devices. Every step — from raw material selection to packaging — is documented and controlled.

Icon for clinically tested safety of PMA-Zeolite

Clinically tested safety

Studies confirm: no aluminum is released, even after months of use. The high silicon content ensures the stability of the crystal lattice.

Icon for PMA-Zeolite production in Carinthia, Austria

100% Made in Austria

Raw material selection, PMA activation, and final inspection — everything takes place in Carinthia, Austria. Short distances, highest standards, full traceability.

Science

Clinical studies on PMA-Zeolite

The effectiveness and safety of PMA-Zeolite are documented in numerous peer-reviewed studies.

Peer-Reviewed

Strengthening the intestinal barrier

Double-blind, placebo-controlled study: PMA-Zeolite improves intestinal wall integrity and significantly reduces inflammatory markers. Zonulin as a leaky gut marker was clearly reduced.

Clinical study

Selective binding of heavy metals

PMA-Zeolite selectively binds lead, cadmium, and arsenic in the gastrointestinal tract — without negatively affecting mineral balance. Controlled clinical study.

Safety

No aluminum release

After 3 months of daily use: aluminum levels in the blood remained unchanged. The stable SiO₄/AlO₄ lattice releases no aluminum — clinically confirmed.

Clinical study

Reduction of oxidative stress

PMA-Zeolite shows antioxidant properties: reduction of malondialdehyde (MDA) and other oxidation markers with regular intake.

View all studies
Our products

The right PMA-Zeolite product for you

All PANACEO medical devices are based on PMA-Zeolite — CE-certified, clinically tested, made in Austria.

FAQ

Frequently asked questions about PMA-Zeolite

PMA-Zeolite is a patented medical device by PANACEO based on clinoptilolite zeolite. Through PMA activation (Patented Micro Activation), the adsorption power is enhanced — for optimal binding of harmful substances in the gut and a strengthened intestinal barrier.
PMA stands for Patented Micro Activation — a patented mechanical process that optimizes the crystal structure, increases the inner surface area, and multiplies the binding of harmful substances. No other manufacturer uses this technology.
Regular zeolite has an irregular crystal structure. PMA activation optimizes it: larger surface area, uniform particle size (1–10 µm), higher binding of harmful substances. In addition, PMA-Zeolite is CE-certified (Class IIb) — unlike many uncertified products.
Yes. Certified as a Class IIb medical device according to ISO 13485. More than 6 million products sold and 20+ years of market experience confirm its long-term safety. Clinical studies show: no aluminum release, even after months of use.
Entirely in Austria — from raw material selection to PMA activation and final inspection. Everything takes place under strict quality standards in Carinthia.